OQS
DCPH

Occudo Quantitative Strategies’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Occudo Quantitative Strategies’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-47,975
Closed -$786K – 1272
2022
Q4 		$786K Sell
47,975
-62,656
-57% -$1.02M 0.09% 359
2022
Q3 		$2.05M Buy
+110,631
New +$1.74M 0.16% 176
2022
Q1 		– Sell
-147,559
Closed -$1.44M – 1369
2021
Q4 		$1.44M Buy
+147,559
New +$2.77M 0.13% 238

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Occudo Quantitative Strategies's DCPH Position: Q1 2023 in Review

Occudo Quantitative Strategies sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2023, closing a stake of 47,975 shares — an estimated $786K sold.

Occudo Quantitative Strategies first reported a position in DCPH in Q4 2021 and held it in 3 quarters. The position peaked at $2.05M in Q3 2022. 146 funds tracked by Wall St. Rank hold DCPH as of Q1 2023.

  • Occudo Quantitative Strategies reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 47,975 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $786K.
  • Occudo Quantitative Strategies first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $2.05M in Q3 2022.
  • 146 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.